The cardiovascular medicine market in South Korea, measured in value, stood at 4.94 billion USD in 2024. From 2024 and onwards, the market shows a consistent year-on-year growth with values reaching 5.15 billion USD in 2025, 5.36 billion USD in 2026, 5.56 billion USD in 2027, and 5.76 billion USD in 2028. This represents year-on-year increases of approximately 4.3% annually between 2024 and 2028. The Compound Annual Growth Rate (CAGR) for this period is about 3.9%.
Future trends to watch for include:
- Advancements in cardiovascular treatments and innovations in medicine.
- Government healthcare policies and funding affecting market dynamics.
- Increasing prevalence of cardiovascular diseases driven by lifestyle changes.
- Potential impact of emerging telehealth and digital health technologies.
- Market entry of new competitors and generic medicines.
